Showing results (991-1000 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1992
Predictors of placebo response: a retrospective analysisC S Wilcox, J B Cohn, R D Linden, et al.Psychopharmacology Bulletin|January 1, 1992
Debrisoquine hydroxylation phenotyping in geriatric psychopharmacologyB G Pollock, J M Perel, L P Altieri, et al.Psychopharmacology Bulletin|January 1, 1992
Pimozide in autistic childrenM Ernst, H J Magee, N M Gonzalez, et al.Psychopharmacology Bulletin|January 1, 1992
Profile of a sample of subjects admitted to an acute care psychiatric facility with manic symptomsP A Marken, S W Stanislav, S Lacombe, et al.Psychopharmacology Bulletin|January 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decreaseJ W Newcomer, S J Riney, S Vinogradov, et al.Psychopharmacology Bulletin|January 1, 1992
Buprenorphine for cocaine and opiate dependenceT R Kosten, M I Rosen, R Schottenfeld, et al.Psychopharmacology Bulletin|January 1, 1992
Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophreniaM H Chakos, D I Mayerhoff, A D Loebel, et al.Psychopharmacology Bulletin|January 1, 1991
Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepamC L DeVane, M R Ware, R B LydiardPsychopharmacology Bulletin|January 1, 1991
Down-regulation of beta receptors by desipramine in vitro involves PKC/phospholipase A2H K Manji, G A Chen, J A Bitran, et al.Psychopharmacology Bulletin|January 1, 1996
A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobiaD Bakish, C L Hooper, M J Filteau, et al.Pageof 128